|
NIH CEAL celebrates women who are making an impact on COVID-19 science and treatment
This Women’s History Month, we draw your attention to the 28 diverse women who are part of the CEAL Scientific Pathway. These women — including researcher Kizzmekia S. Corbett, Ph.D., who helped develop the Moderna COVID-19 vaccine, Hsin-Chieh Yen, Ph.D., who worked to ensure the safety of the vaccine, and teenage clinical trial participant Julia Kachar — are making history for their contributions to COVID-19 research and treatment.
|
|
 Dr. Corbett, immunologist and clinical researcher
|
 Dr. Yeh, epidemiologist and clinical trial safety monitor
|
 Julia Kachar, clinical trial participant
|
|
 Dr. Bottazzi, microbiologist and pediatric infectious disease researcher
|
New member: Dr. Maria Bottazzi
The newest member to the CEAL Scientific Pathway is Maria Elena Bottazzi, Ph.D., co-director of Texas Children’s Hospital Center for Vaccine Development in Houston. As a microbiologist and pediatric infectious disease researcher, Dr. Bottazzi worked on developing safe and effective vaccines against SARS and MERS and is now working on COVID-19. “Critical to this effort is building trust in science and trust in research so that people, regardless of whether they live in India, Honduras, or the U.S., understand that vaccines are safe, effective, and essential to prevent or reduce COVID-19,” she said.
|
|
Know your COVID-19 community level
Nationally, new COVID-19 guidance aims to get the country back to more in-person activities. However, what’s going on nationally may be different from what’s true in counties where you live, work, worship, and play. Updated weekly, CDC's new COVID-19 by County tool shows your county’s level and what prevention steps to take based on those numbers.
|
|
Share your stories about health misinformation
The U.S. Surgeon General would like you to share your research, data, and personal experiences related to health misinformation. Stories and information submitted in response to this Request for Information (RFI) will be used to prepare for and respond to future public health crises. The information and related comments will be made available to the public and for research purposes. Read more about the RFI and how to submit your comments, which are due by May 2, 2022.
|
|
How COVID-19 immunity holds up over time
A new study shows the importance of keeping our vaccines up to date as coronavirus variants continue to circulate, as Lawrence Tabak, D.D.S., Ph.D., wrote in his latest NIH Director’s Blog. The study, published in “Science Translational Medicine,” shows that antibody levels generated after two doses of either the Pfizer or Moderna vaccines dropped considerably after six months.
|
|
Grant available to explore COVID-19 testing options
RADx-UP, an NIH initiative, is offering a $200,000 grant for researchers exploring ways to provide COVID-19 testing in communities hardest hit by the pandemic. The application deadline is May 13, 2022. Sign up for the informational webinar to be held March 23, 2022, from 2-3 p.m. EDT.
|
|
Get additional, free at-home COVID-19 tests
You can now order additional free COVID-19 tests, even if you already received four free ones. They will be mailed to your home. Order the tests online or call 1-800-232-0233 for help in Spanish or other languages.
|
|
Tools for creating a COVID-19 vaccine campaign
The Makespace project was established to help community leaders create and disseminate messaging during a public health emergency. By using templates and other existing materials, community leaders can easily create customized social media posts, comics, stickers, posters, and more for their communities. The project is supported by CDC, the University of Minnesota’s National Resource Center for Refugees, Immigrants, and Migrants; and IDEO.org.
|
|
Explore Popular CEAL Resources |
|
Journey to COVID-19 Vaccines infographic
|
Q&A About Booster Shots for COVID-19 fact sheet
|
|
|
|
|
